H.I.G. Capital Recapitalizes Navitas Life Sciences

September 13, 2022

An affiliate of H.I.G. Capital completed the recapitalization of Navitas Life Sciences, a Princeton, New Jersey–based technology-enabled clinical research organization (CRO). The transaction follows H.I.G.'s earlier agreement to acquire a majority (~75%) stake from TAKE Solutions and will provide Navitas with capital and resources to accelerate growth and expand its technology-enabled CRO capabilities.

Buyers
H.I.G. Capital
Targets
Navitas Life Sciences
Sellers
TAKE Solutions Limited
Location
New Jersey, United States
Transaction Type
Recapitalization

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.